City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
NCT Number: NCT00937989
RATIONALE: Gathering information about barriers to receiving breast cancer treatment may help doctors learn more about improving the treatment process and improve patients' quality of life.
PURPOSE: This clinical trial is studying barriers to beginning and finishing treatment for patients with breast cancer.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Duarte, California, 91010-3000, United States
OBJECTIVES:
OUTLINE: For the first 3 months of the study, medical charts are reviewed.
Beginning in month 4, patients are introduced to the Patient Navigator who provides them with telephone and e-mail contact on an Appointment Reminder Card, and develops a plan for eliminating identified barriers and/or addressing immediate concerns. Patients' plans may include contacting others on behalf of the patient, coaching the patient on how to solve a problem, referring to resources within City of Hope (COH) or in the community, and investigating possible solutions. Patients are also oriented to COH's services, open clinical trials, and resources. Navigation of care includes assistance during initial and ongoing evaluations by all cancer specialists, during initiation and completion of all primary treatment, and through the first post-treatment follow up. Patients are contacted weekly for 8 weeks of the study and at least once a month for 9 months.
The Patient Navigator will track identified barriers, processes to resolution, and time required to resolve barriers.
Patients complete questionnaires at baseline, and periodically during study, on socio-demographic, quality of life, resource-use satisfaction, and satisfaction with care and Patient Navigator.
After completion of study intervention, patients continue to receive Patient Navigator support for up to 30 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Occurs weekly during the first 8 weeks of the study and thereafter a minimum of monthly through the 9th month of the study.
Occurs weekly during the first 8 weeks of the study and thereafter a minimum of monthly through the 9th month of the study.
Baseline, 3, 6 and 9 months after starting the study
Baseline, 3, 6 and 9 months after starting the study
Baseline, 3, 6 and 9 months after starting the study
Baseline, 3, 6 and 9 months after starting the study
Time frame: Weekly during the first 8 weeks of the study and thereafter a minimum of monthly through the 9th month of the study.
Time frame: Prior to starting treatment and 3, 6 and 9 months after starting the study.
Time frame: 3, 6 and 9 months after starting the study.
City of Hope Medical Center
Other
Patient Navigation in Breast Cancer Care; Addressing Barriers to Treatment Initiation, Completion, and Follow Up
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00666731
Adenocarcinoma, Breast Cancer
Colorado Springs, Colorado, United States
View Trial DetailsNCT00438659
Adenocarcinoma, Breast Cancer
Aurora, Illinois, United States
View Trial DetailsNCT01556243
Adenocarcinoma, Breast Cancer
Hot Springs, Arkansas, United States
View Trial DetailsNCT00898508
Adenocarcinoma, Breast Cancer
Beverly Hills, California, United States
View Trial Details